© 2018 by ICD Pharma. 

Injecting Science

into Cannabis

About Us

ICD Pharma is developing Cannabis-based medicines, which will soon be available for patients and doctors around the world. 

Our product pipeline includes Cannabis-based products in unique formulations, based on a portfolio of proprietary pharmaceutical delivery technologies, developed to address a variety of unmet clinical needs.

Based on many years of pharmaceutical development and with a track record of numerous drugs brought to market, we are creating a portfolio of best-in-class Cannabis-based therapies relying on novel formulations.

 
 

Our Vision

ICD Pharma's vision is to become a global leader in development of Cannabis based medicines for better, more effective and patient friendly care.

 

What we do

Breakthrough technologies Improved performance

Better patient experience

Oral High
Dose Capsules
Colonic Release
Cannabis Tablets
Enhanced
Absorption Tablets
Skin Penetrating
Cannabis Cream
Cannabis Infused
Flavoured Syrups
Synergistic Anti-Inflammatory
Cannabis Cream

What Patients Say

"It is always a battle to give Jane the oil, she dislikes the taste and when we mixed it with yogurt and other food, we never know how much she really consumes.

I wish there was non-oily, tasty syrup that she can take with a smile"

 
 

ICD Pharma Founders

Dr. Doron Friedman

30 years of innovative formulations development.

Eran Tor

25 years of CEO and leadership experience in consumer brand and retail management around the world.

Eran Perry

20 years of management and investment experience, life science

VC investments, entrepreneurship,

and big pharma.

 

Get in Touch

injecting Science into Cannabis and Improving Patients Care.